Inhibition of Soluble Epoxide Hydrolase Prevents Docetaxel-Induced Painful Peripheral Neuropathy
Open Access
- 12 June 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (12) , 5630
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is a painful condition recalcitrant to current available therapies. CIPN pain can be severe and dose-limiting or dose-reducing for life-extending chemotherapeutics and, to date, there is no treatment to alter the progression of CIPN. For these experiments we used docetaxel, a first-line therapy for metastatic prostate cancer in humans and investigated the soluble epoxide hydrolase inhibitor EC5026 for its analgesic efficacy against this CIPN pain. Male SD rats (n = 10/group) were pretreated with 1 mg/kg EC5026 in formulated drinking water or vehicle for one week prior to docetaxel injections. The rats continued the formulated drinking water during three once-a-week docetaxel 10 mg/kg i.p. injections and were maintained on treatment until the end of week 5 when all groups were transitioned to normal drinking water. Nociceptive testing occurred throughout the entire experiment including after transitioning to normal drinking water. EC5026 increased mechanical withdrawal thresholds and latencies on the cold plate compared to docetaxel-treated controls. There were no motor effects of the compound, and the formulated drinking water provided favorable exposure. These results demonstrated that EC5026 administered prophylactically was both analgesic and able to limit the severity of mechanical and cold sensitivities in the docetaxel CIPN rat model.Keywords
Funding Information
- National Institute of Environmental Health Sciences (NIEHS) (R35ES030443, P42 ES004699)
- NIEHS Superfund Research Program (R35ES030443, P42 ES004699)
This publication has 81 references indexed in Scilit:
- Validity of Patient-Reported Outcome Measures in Evaluating Nerve Damage Following ChemotherapyJAMA Network Open, 2024
- Proteomic analysis discovers potential biomarkers of early traumatic axonal injury in the brainstemInternational journal of legal medicine, 2023
- Current and projected number of years of life lost due to prostate cancer: A global studyThe Prostate, 2022
- Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicinSupportive Care in Cancer, 2021
- Body regional heat pain thresholds using the method of limit and level: a comparative studyEuropean Journal of Applied Physiology, 2019
- Chemotherapy‐induced peripheral neuropathy: A current reviewAnnals of Neurology, 2017
- The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of FallingJAMA Neurology, 2016
- Mechanical allodyniaPflügers Archiv - European Journal of Physiology, 2014
- Cress and Potato Soluble Epoxide Hydrolases: Purification, Biochemical Characterization, and Comparison to Mammalian EnzymesArchives of Biochemistry and Biophysics, 2000
- Distribution and properties of a mammalian soluble epoxide hydraseBiochemical Pharmacology, 1980